Skip to search formSkip to main contentSkip to account menu

(124)I-cMAb U36

Known as: 124I-cMAb U36 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Monoclonal AntibodiescMAb U36

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas.
2007
2007
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies
PurposeWe tested the suitability of the chimeric monoclonal anti-human CD44 splice version 6 antibody (cMAb U36) for targeting… 
2007
2007
Radioimmunotherapy With Astatine‐211 Using Chimeric Monoclonal Antibody U36 in Head and Neck Squamous Cell Carcinoma
Objectives: In advanced head and neck squamous cell carcinoma (HNSCC), there is a need for an adjuvant treatment. We aim to… 
2005
2005
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
PurposeThe purpose of this study was to analyse the properties of the astatinated chimeric MAb (cMAb) U36 as a conjugate to… 
Highly Cited
2004
Highly Cited
2004
High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy
PurposeMonoclonal antibodies (MAbs) labelled with 124I are an attractive option for quantitative imaging with positron emission… 
2003
2003
Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods.
We have evaluated the applicability of the [(4-isothiocyanatobenzylammonio)undecahydro-closo-dodecaborate (1-)] (DABI) linker… 
2002
2002
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose…
PURPOSE In an earlier Phase I radioimmunotherapy (RIT) study with rhenium-186-labeled chimeric monoclonal antibody (cMAb) U36 in… 
2001
2001
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and… 
Highly Cited
2000
Highly Cited
2000
Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy
Coupling of photosensitizers to tumor‐selective monoclonal antibodies ( MAbs ) is an attractive option for improving the… 
1997
1997
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice
Abstract At our laboratory we are currently evaluating the suitability of mouse/human chimeric monoclonal antibodies (cmAb) for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)